The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …

Acute hepatitis for intravenous amiodarone is an uncommon problem with scarce
appearances in medical literature. Sometimes, it has postulated that the vehicle of the …

A 61 year old man, treated with amiodarone since 1993 for resistant supraventricular
arrhythmias, developed acute hepatitis after an intravenous amiodarone administration …

BACKGROUND Amiodarone is the drug most commonly used to manage arrhythmias. Long-
term amiodarone administration causes hepatotoxicity due to iodine accumulation in the …

Discussion Amiodarone hydrochloride is an antiarrhythmic agent currently undergoing
clinical trials in the United States. It has proven useful in the therapy of refractory …

We report a patient with classical features of amiodarone hepatotoxicity who died of
progressive liver failure. Throughout the course of his illness, he had epigastric pain …

Background: Amiodarone-induced hepatotoxicity consists of mild liver test abnormalities and
rare cases of acute hepatitis and chronic hepatic lesions, and histologically resembles the …

This is a case report in which a 60-year-old man who suffered from ventricular tachycardia
with dilated cardiomyopathy was prescribed amiodarone. After taking amiodarone, liver …